This comes as US President Donald Trump has declared opioid addiction a public health emergency in the US and drugmakers have found themsel...

Trumping bigger rivals Aurobindo, Intas shot into the limelight on Wednesday, scooping up Teva's assets in the UK and Ireland in a $764 mil...

With the acquisition of Teva’s products, sold through erstwhile Actavis’ operations, Intas is set to emerge as a top player in the UK gener...

If successful, this would be Aurobindo's largest ever acquisition, surpassing its $132.5 mn purchase of US vitamin maker Natrol Inc in 2014.

Roche has challenged the regulator and pleaded to block the approvals of the drugs under review, ET learned from highly placed legal source...

Hyderabad based Hetero pharma has launched biosimilar drug Rituximab under the brand name of MABALL, used in the treatment of blood cancer.

The doctors’ regulatory body is also in the process of sending a letter to the Drug Controller General of India, urging it to warn and take...

Developed economies can learn a few lessons from the way India is going about creating a comprehensive global intellectual property rights ...

Temasek Holding's proposed 10.16% stake purchase in Indian firm Intas Pharmaceuticals has got the approval of the Competition Commission.

An affidavit of objection challenging Intas' amalgamation was filed by Mani Iyer, a former executive director of Intas Biopharmaceuticals, ...

Private equity firm ChrysCapital is buying an additional stake in Intas Pharmaceuticals for Rs 300 crore after the Ahmedabad-based drug mak...

Although the stake could not be be confirmed, the pre-IPO deal will increase ChrysCapital's holding in the company to over 15% from 11.3% c...

3 PE firms are vying for a minority stake in generic drugmaker Intas Pharmaceuticals, two people familiar with the development told ET.

Intas Biopharmaceutical Ltd, a group company of the Rs 1,600-crore Intas Pharmaceuticals Ltd, would soon enter into an out-licensing and su...

Intas Pharma plans to raise Rs 750-800 cr through IPO that will help it raise fresh funds for acquisitions besides allowing PE investor Chr...

A clutch of investors are set to pick up 47% stake in the Intas Biopharmaceuticals, the biotech arm of Ahmedabad-based pharma major Intas P...

Venture capital firm GVFL Ltd on Wednesday said it has picked up stake worth Rs 2 crore in Ahemdabad-based Celestial Biologicals Ltd throug...